132 related articles for article (PubMed ID: 14614031)
1. Correspondence re: J. Lu et al., thalidomide metabolites in mice and patients with multiple myeloma. Clin. Cancer Res., 9: 1680-1688, 2003.
Zhou S
Clin Cancer Res; 2003 Nov; 9(14):5429; author reply 5429. PubMed ID: 14614031
[No Abstract] [Full Text] [Related]
2. Correspondence re: K. Neben et al., high plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin. Cancer Res., 7: 2675-2681, 2001.
Go RS; Horstman AL
Clin Cancer Res; 2002 Aug; 8(8):2750; author reply 2751. PubMed ID: 12171909
[No Abstract] [Full Text] [Related]
3. Thalidomide metabolites in mice and patients with multiple myeloma.
Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Muller G; Ching LM
Clin Cancer Res; 2003 May; 9(5):1680-8. PubMed ID: 12738721
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patients.
Chung F; Lu J; Palmer BD; Kestell P; Browett P; Baguley BC; Tingle M; Ching LM
Clin Cancer Res; 2004 Sep; 10(17):5949-56. PubMed ID: 15355928
[TBL] [Abstract][Full Text] [Related]
5. [Thalidomide for the treatment of refractory multiple myeloma].
Kakimoto T; Hattori Y; Okamoto S
Rinsho Ketsueki; 2002 May; 43(5):345-8. PubMed ID: 12096483
[No Abstract] [Full Text] [Related]
6. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide--a treatment for cancer?
Mayo Clin Health Lett; 2000 Jun; 18(6):4. PubMed ID: 10868128
[No Abstract] [Full Text] [Related]
8. Thalidomide shows promise as cancer treatment.
Health News; 2000 Jan; 6(1):8. PubMed ID: 11019665
[No Abstract] [Full Text] [Related]
9. [Multiple myeloma: the role of angiogenesis and therapeutic application of thalidomide].
Jurczyszyn A; Wolska-Smoleń T; Skotnicki AB
Przegl Lek; 2003; 60(8):542-7. PubMed ID: 14974349
[TBL] [Abstract][Full Text] [Related]
10. On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma.
Ribatti D; Vacca A
Ann Hematol; 2003 Apr; 82(4):262. PubMed ID: 12707735
[No Abstract] [Full Text] [Related]
11. [Thalidomide: (re)discovery of a not very dear old molecule].
Bressoud A; Schwab BZ
Rev Med Suisse Romande; 2003 Apr; 123(4):238-40. PubMed ID: 15088555
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide: present and future in multiple myeloma.
Hussein MA
Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
[TBL] [Abstract][Full Text] [Related]
13. [Thalidomide and others: new treatment for myeloma].
Malphettes M; Fermand JP
Rev Prat; 2003 Oct; 53(15):1633-5. PubMed ID: 14689905
[No Abstract] [Full Text] [Related]
14. Thalidomide.
Waldman AR
Clin J Oncol Nurs; 2000; 4(2):99-100. PubMed ID: 11107384
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of thalidomide in the treatment of multiple myeloma.
Warzocha K; Kraj M; Pogłód R; Szpila T; Mendek-Czajkowska E; Chełstowska M; Tronina RH
Acta Pol Pharm; 2008; 65(6):771-4. PubMed ID: 19172865
[No Abstract] [Full Text] [Related]
16. Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients.
Corso A; Lorenzi A; Zappasodi P; Invernizzi R; Vanelli L; Lazzarino M
Haematologica; 2003 Aug; 88(8):958-60. PubMed ID: 12935985
[No Abstract] [Full Text] [Related]
17. [New observations support the significance of angiogenesis in myeloma].
Lundberg LG; Lerner R; Palmblad J
Lakartidningen; 2001 Nov; 98(45):4985-90. PubMed ID: 11816901
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide--a revival story.
Raje N; Anderson K
N Engl J Med; 1999 Nov; 341(21):1606-9. PubMed ID: 10564693
[No Abstract] [Full Text] [Related]
19. Why not start with thalidomide?
Loprinzi C; Rajkumar SV
J Clin Oncol; 2003 Jun; 21(11):2211-4. PubMed ID: 12775748
[No Abstract] [Full Text] [Related]
20. Thalidomide and lenalidomide in the treatment of multiple myeloma.
Kumar S; Rajkumar SV
Eur J Cancer; 2006 Jul; 42(11):1612-22. PubMed ID: 16750621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
